Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |